Logo FIGO 2018 | World Congress of Gynecology and Obstetrics
#FIGO2018 #EveryWomanMatters

ABSTRACT SUBMISSION GUIDELINES

The Scientific Programme Committee invites the submission of abstracts for scientific presentations at the most important international academic event in our specialty, the XXII FIGO World Congress.

SUBMISSION GUIDANCE

Submission format

  • Abstracts are limited to 2.500 characters (including spaces).
  • Each application should specify whether it is for an oral or a poster presentation.
  • Oral presentations will be allocated 7 minutes for the presentation with an additional 3 minutes for questions and audience interaction.
  • Poster presentations will be in the format and size that will be conveyed after acceptance.
  • The Scientific Programme Committee may reassign submitted presentations between the two formats as per its discretion.

Submission limit

  • Only one presentation will be permitted to one designated presenter.
  • There are no restrictions on the number of abstracts submitted
  • Abstracts submitted to other international meetings must not be submitted and will not be accepted.

Presenting delegate

  • The presenting author must be a registered congress delegate.
  • Only the name of the presenting author will appear in the final congress programme.
  • Presenters whose abstracts have been accepted must register for the Congress and pay the registration fee before the registration deadline.
  • Failure to register in time may result in exclusion from the programme.

Language of submission

  • All abstracts must be submitted and presented in English.

Category of submission

  • The submission category for the abstract should be as per the official listing.
  • The one category considered most suitable for the oral or poster presentation should be selected.

Acceptance notification

  • Presenters will be notified regarding acceptation of their abstracts by April 30, 2018.
  • Presenters whose abstracts have been accepted must register for the Congress and pay the registration fee before May 15, 2018.
  • Failure to register in time may result in exclusion from the programme.
  • Further details and instructions for oral and poster presentation would be conveyed after that time.

ABSTRACT CONTENT AND FORMAT

Online abstract form is divided into the following sections

Objective

  • Concise statement on why the study was conducted.

Method

  • Location, number and type of human subjects, non-human species or material being studied.
  • Design of the study and type of intervention.
  • Principal assays or test(s) performed and the types of statistical analyses if appropriate.

Results

  • Main findings and results should be reported.
  • Results should be supported by statistical analysis where appropriate

Conclusions

  • Main conclusions of the study and significance of the results.
  • How the results may affect patient management or understanding of the condition.

Important caveats

  • Proof read abstract carefully before submitting.
  • Only use standard abbreviations if indicated.
  • Abstracts stating merely that the results will be presented or discussed at the congress may be rejected.
  • The use of tables and images in the abstract is not allowed.
  • Submissions by email, fax and post will not be accepted.
  • If you experience any technical difficulties, please email: abstractbrasil@mci-group.com

IMPORTANT DATES

Submission deadline – March 15, 2018
Notification deadline – April 30, 2018
Registration deadline for presenters – May 15, 2018

For a better system performance, please, use the Firefox or Chrome Browser.

SUBJECT CATEGORIES FOR SUBMISSION OF ABSTRACTS

Please select the one that is most suitable for the presentation or poster submission:

AB 1 Maternal Fetal Health

  • AB 1.1 Prenatal Diagnosis
  • AB 1.2 Imaging in Obstetrics
  • AB 1.3 Assessment of Fetal Wellbeing
  • AB 1.4 Medical Disorders in Pregnancy
  • AB 1.5 High Risk Pregnancy

AB 2 Clinical Obstetrics

  • AB 2.1 Antenatal and Postnatal Care
  • AB 2.2 Labor and Delivery
  • AB 2.3 Operative Obstetrics
  • AB 2.4 Infections in Obstetrics
  • AB 2.5 Midwifery Care
  • AB 2.6 Neonatal Care

AB 3 General Gynecology

  • AB 3.1 Pediatric and Adolescent Gynecology
  • AB 3.2 Gynecological Care for the Older Woman
  • AB 3.3 Imaging in Gynecology
  • AB 3.4 Benign Conditions in Gynecology
  • AB 3.5 Infections in Gynecology

AB 4 Operative Gynecology

  • AB 4.1 Conventional and Benign Gynecological Surgery
  • AB 4.2 Minimal Access Surgery including Robotic Surgery
  • AB 4.3 Innovations in Gynecological Surgery
  • AB 4.4 Safe Surgical Techniques and Practice

AB 5 Reproductive Medicine

  • AB 5.1 Reproductive Endocrinology
  • AB 5.2 Management of Subfertility
  • AB 5.3 Male Infertility
  • AB 5.4 Assisted Reproduction
  • AB 5.5 Disorders of Sexual Development

AB 6 Sexual and Reproductive Health and Rights

  • AB 6.1 Contraception and Family Planning
  • AB 6.2 Termination of Pregnancy
  • AB 6.3 Human Sexuality
  • AB 6.4 Sexual and Reproductive Rights
  • AB 6.5 Awareness and Counselling in Sexual and Reproductive Health

AB 7 Urogynaecology

  • AB 7.1 Preventive Urogynecology
  • AB 7.2 Genital Prolapse – Management and Surgery
  • AB 7.3 Incontinence – Management and Surgery
  • AB 7.4 Genital Trauma and Fistulae

AB 8 Gynecological Oncology

  • AB 8.1 Preventive Oncology
  • AB 8.2 Diagnosis and Management of Gynecological Malignancies

AB 9 Women’s Health Issues and Policy

  • AB 9.1 Addressing Maternal Mortality
  • AB 9.2 Sustainable Development Goals
  • AB 9.3 Medical Education and Training
  • AB 9.4 Information Technology in Women’s Health
  • AB 9.5 Ethics and Law in Women’s Health

AB 10 Special Topics

  • AB 10.1 Women and the Environment
  • AB 10.2 Addressing Stigma and Violence against Women
  • AB 10.3 Women’s Health in Situations of Conflict and Disaster
  • AB 10.4 Research Methodology, Conduct and Dissemination
  • AB 10.5 Evidence Based Medicine and Guidelines